Search Results 441-450 of 18878 for Neutrophil

1. Lenalidomide and AT-101 in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia - Mayo Clinic

   Absolute neutrophil count ≥ 1500/mm^3; Platelet count ≥ 30,000/mm^3; Serum creatinine ≤ 1.5 x upper limit of normal (ULN); Total bilirubin ≤ 1.5 mg/dL or ...

2. Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1.5 x 109/L,; Hemoglobin (Hgb) ≥ 90 g/L,; Platelets (plt) ≥ 100 x 109/L,; Potassium within normal range, or correctable ...

3. Study of rSIFN-co for Patients with Advanced Solid Tumors - Mayo Clinic

   ... neutrophil count (ANC) ≥1.5 ×10⁹/L , and platelet count ≥100,000/mm³; Subjects who received chemotherapy for melanoma just prior to screening need to have ...

4. Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer - Mayo Clinic

   Absolute neutrophil count ≥ 1500/mcL;; Hemoglobin ≥ 9.0 g/dL;; Platelets ≥ 100,000/mcL;; Total bilirubin ≤ 1.5 x the upper limit of normal (ULN);; SGPT (ALT) ...

5. Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery - Mayo Clinic

   Absolute neutrophil count >= 1,500/mm^3; Platelets >= 100,000/mm^3; Total bilirubin =< the upper limit of normal (ULN); Calculated creatinine clearance must be > ...

6. Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or In Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

   Absolute neutrophil count ≥ 1,500/ mm^3; Platelets ≥ 100,000/mm^3; Hemoglobin ≥ 9 g/dL; Total bilirubin ≤ 1.5 institutional upper limit of normal (ULN) ...

7. A Study to Evaluate the Safety and Effectiveness of Metformin and Nelfinavir with Bortezomib in Patients with Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1000/mm^3;; Platelet count 50,000/mm^3 or > 30,000/mm^3 if bone marrow plasma cells percentage > 50% by morphology. (No ...

8. A Study to Compare Tisagenlecleucel vs. Standard of Care in Adult Patients with Aggressive B-cell Non-Hodgkin Lymphoma - Mayo Clinic

   Absolute neutrophil count (ANC) >1000/mm^3;; Absolute lymphocyte count (ALC) >300/mm^3;; Absolute number of CD3+ T cells >150/mm^3;; Platelets ≥50000/mm^3 ...

9. A Study Using Chemotherapy Followed by Radiation Therapy in Treating Younger Patients with Newly Diagnosed Localized Central Nervous System Germ Cell Tumors - Mayo Clinic

   Peripheral absolute neutrophil count (ANC) ≥ 1,000/μL; Platelet count ≥ 100,000/μL (transfusion independent); Hemoglobin ≥ 8.0 g/dL (may receive red blood ...

10. A Study of Safety, Tolerability, Pharmacokinetic and Pharmacodynamics (PK/PD) in Patients With Hematologic Malignancies - Mayo Clinic

    Absolute neutrophil count (ANC) ≥1.0 X 109/L. 9. Hemoglobin ≥ 8.0 g/dL. 10. Platelets count ≥ 30 X 109/L (entry platelet count must be independent of ...